On Friday, Wave Life Sciences Ltd (NASDAQ: WVE) opened higher 2.43% from the last session, before settling in for the closing price of $13.19. Price fluctuations for WVE have ranged from $3.50 to $16.74 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 610.91% over the last five years. Company’s average yearly earnings per share was noted -113.04% at the time writing. With a float of $117.59 million, this company’s outstanding shares have now reached $148.39 million.
The firm has a total of 268 workers. Let’s measure their productivity. In terms of profitability, gross margin is 16.52%, operating margin of -283.63%, and the pretax margin is -265.84%.
Wave Life Sciences Ltd (WVE) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Wave Life Sciences Ltd is 22.90%, while institutional ownership is 73.93%. The most recent insider transaction that took place on Nov 25 ’24, was worth 750,000. In this transaction President and CEO of this company sold 50,000 shares at a rate of $15.00, taking the stock ownership to the 217,351 shares. Before that another transaction happened on Nov 25 ’24, when Company’s Officer proposed sale 50,000 for $15.00, making the entire transaction worth $750,000.
Wave Life Sciences Ltd (WVE) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -113.04% per share during the next fiscal year.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
Check out the current performance indicators for Wave Life Sciences Ltd (WVE). In the past quarter, the stock posted a quick ratio of 1.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 39.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.11, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -1.06 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Analysing the last 5-days average volume posted by the [Wave Life Sciences Ltd, WVE], we can find that recorded value of 1.74 million was better than the volume posted last year of 1.12 million. As of the previous 9 days, the stock’s Stochastic %D was 15.22%. Additionally, its Average True Range was 0.99.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 72.42%, which indicates a significant increase from 23.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 83.69% in the past 14 days, which was lower than the 131.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.20, while its 200-day Moving Average is $8.06. Now, the first resistance to watch is $13.93. This is followed by the second major resistance level at $14.35. The third major resistance level sits at $14.85. If the price goes on to break the first support level at $13.01, it is likely to go to the next support level at $12.51. Should the price break the second support level, the third support level stands at $12.09.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
There are currently 152,520K shares outstanding in the company with a market cap of 2.11 billion. Presently, the company’s annual sales total 113,310 K according to its annual income of -57,510 K. Last quarter, the company’s sales amounted to 19,690 K and its income totaled -32,920 K.
